News
15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022
The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma
July 4th Is A New Thanksgiving Day – With Two Bullish Surprises
For weekend reading, Gary Alexander, senior writer at Navellier & Associates, offers the following commentary:
Thanksgiving came early this year – on the Fourth of July, as we celebrated a
House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You
Ending the month-long stalemate, the Texas House on Thursday approved the landmark property tax relief bill that was passed by the Senate a day before. The $18 billion Texas property tax relief
Pfizer Just Invested $25 Million In This Biotech
Key Points
- Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
- The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Pfizer Just Invested $25 Million In This Biotech
Key Points
- Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
- The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Agilent Technologies Stock: Ready to Rise off the Floor
Key Points
- Agilent Technologies is a leading laboratory technology and life sciences company.
- Its fiscal Q2 2023 earnings report had revenues climb 6.8% to $1.72 billion with a GAAP net
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
Key Points
- Dexcom is aiming for growth, and this year showcased its G7 sensors in a Super Bowl commercial.
- The company’s stock recently cleared a price consolidation above a $126.54 buy
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
Key Points
- Dexcom is aiming for growth, and this year showcased its G7 sensors in a Super Bowl commercial.
- The company’s stock recently cleared a price consolidation above a $126.54 buy
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Key Points
- Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
- Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Key Points
- Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
- Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Key Points
- Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
- Trading volume was more than double the average as the stock cleared resistance above
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 08. Juni 2023
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 08. Juni 2023
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Lawmakers Sign Off On Law Enforcement Oversight Reforms
Sunset legislation aims to make fundamental changes to operations at the Texas Commission on Law Enforcement, which oversees licensure of law enforcement.
Building Public Confidence In Law
Microbot Medical Spikes 150% on its Endovascular Surgical Robot
Key Points
- Microbot Medical makes remote-controlled micro-robotics systems to assist medical practitioners with minimally invasive surgical procedures.
- Microbot’s LIBERTY robotic system
Vertex Labs Acquires Digimental Studio For Us$12 Million
LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire
Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired
Vertex Labs Acquires Digimental Studio For Us$12 Million
LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire
Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired
Vertex Labs Acquires Digimental Studio For Us$12 Million
LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire
Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired
Zoetis Declares New Dividend, Hinting At Undervaluation
Key Points
- JAB has announced its plans to acquire Pumpkin, a pet insurance platform launched by Zoetis, which is still a minority holder.
- As Zoetis undertakes its plans for sustainable
Chinook Therapeutics Inc: Too Little, Too Late – Muddy Waters
Muddy Waters is short Chinook Therapeutics Inc (NASDAQ:KDNY) because we believe it is highly unlikely that atrasentan, its lead product candidate, will be approved by the FDA. We conclude that
Hideaway at Royalton Blue Waters, die neueste Erweiterung der Blue Diamond Resorts, ist für Buchungen verfügbar
TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Das Hideaway at Royalton Blue Waters, An Autograph Collection All-Inclusive Resort – Adults Only, wurde vor Kurzem in das Portfolio der renommierten Blue
Amgen – Trendumkehr möglich
Amgen – Trendumkehr möglich
Amgen – Trendumkehr möglich
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
Key Points
- Pfizer’s Q1 results top expectations on strength in COVID sales.
- Ex-COVID sales grew by 5% and are expected to accelerate in the 2nd half.
- The stock yields more than 4% and